fingolimod hydrochloride has been researched along with HPV Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaafar, N; Massouh, J; Yamout, BI; Zeineddine, M | 1 |
| Benedetti, MD; Bozzetti, S; Gajofatto, A; Gobbin, F; Marangi, A; Mocella, S; Pea, M; Turatti, M | 1 |
| Macaron, G; Ontaneda, D | 1 |
| Corbett, A; Kermode, AG; Reddel, SW; Triplett, J | 1 |
4 other study(ies) available for fingolimod hydrochloride and HPV Infection
| Article | Year |
|---|---|
Skin warts during fingolimod treatment in patients with multiple sclerosis.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; Male; Multiple Sclerosis; Papillomavirus Infections; Warts; Young Adult | 2019 |
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod.
Topics: Carcinoma, Squamous Cell; Fingolimod Hydrochloride; Human papillomavirus 16; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Tonsillar Neoplasms | 2018 |
Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions".
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts | 2019 |
Warts and all: Fingolimod and unusual HPV-associated lesions.
Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts | 2019 |